Urothelial cancer
- Description
- Available test Fluorescence in situ hybridisation analysis of ThinPrep slides using the UroVysion FISH assay
- Clinical details
- The Urovysion FISH assay is intended for use in conjunction with current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.
- Synonyms
- UroVysion, urothelial cancer, bladder cancer, transitional cell carcinoma, TCC
- Testing site
- Synnovis : Genomics : Guy's Hospital
- Laboratory
- Cancer Genetics
- Sample type and volume required
- ThinPrep slide from urine sample
- Turnaround time
- Current service turnaround times: Urgent 2-7 calendar days; Non-urgent 5-10 calendar days; National targets: Urgent samples 95% reported within 14 days; Non-urgent 95% reprted within 21 days
- Contacts
Cancer Genetics at Guy’s Hospital
Phone: 020 7188 1716
Email: synnovis.seglh-ods@nhs.net
Genetics Department
Guy’s Hospital
Great Maze Pond
London SE1 9RT